Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Mar 14;92(5):949-54.
doi: 10.1038/sj.bjc.6602396.

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years

S Moss  1 , I Thomas, A Evans, B Thomas, L Johns; Trial Management Group
Affiliations
Clinical Trial

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years

S Moss et al. Br J Cancer. .

Abstract

Debate continues over the effectiveness of screening by mammography in women below age 50. We report here on results of screening in the first 10 years of a randomised trial to study the effect on breast cancer mortality of invitation to annual mammography from age 40 to 41 compared to first invitation to the 3-yearly UK national programme at age 50-52. The trial is taking place in 23 NHS breast screening centres. Between 1991 and 1997, 160 921 women were randomised in the ratio 1 : 2 to intervention and control arms. Screening is by two views at first screen and single view subsequently; data on screening up to and including round five are now complete. Uptake of invitation to screening is between 68 and 70% at all but the latest screening rounds. Rates of referral for assessment are 4.6% at first screen and 3.4% at subsequent screens. Invasive cancer detection rates are 0.09% at first screen, and similar at rescreens until the sixth and later screens. There is little evidence of regular mammography in the trial control arm. The setting of this trial within the NHS breast screening programme should ensure applicability of results to a national programme.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the progress through the phases of the trial.
See this image and copyright information in PMC

References

    1. Anderson TJ, Sufi F, Ellis IO, Sloane JP, Moss S (2002) Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum Pathol 33: 365–371 - PubMed
    1. Day NE (1985) Estimating the sensitivity of a screening test. J Epidemiol Community Health 39: 364–366 - PMC - PubMed
    1. Forrest APM (1986) Breast Cancer Screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO
    1. Hendrick RE, Smith RA, Rutledge JH, Smart CR (1997) Benefit of screening mammography in women aged 40–49; a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 22: 87–92 - PubMed
    1. Miller AB, To T, Baines CJ, Wall C (2002) The Canadian National Breast Screening Study-1: breast cancer mortality after 11–16 years of follow-up. Ann Intern Med 137: E-305–E-315 - PubMed

Publication types